Australia - englanti - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - levetiracetam, quantity: 500 mg - injection, concentrated - excipient ingredients: sodium chloride; sodium acetate trihydrate; glacial acetic acid; water for injections - levetiracetam concentrate solution for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible.,levetiracetam concentrate solution for iv infusion is indicated for:,? use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation.,? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy.,? add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme).,? add on therapy in the treatment of primary generalised tonic-clonic (pgtc) seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - acetic acid glacial - vaginal gel - 9.4mg/1gram

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - soya bean oil, refined; medium chain triglycerides; refined soyabean oil; fish oil, rich in omega-3 acids; l-alanine; l-arginine; glycine (aminoacetic acid); l-histidine; l-isoleucine; l-leucine; l-lysine; l-methionine; l-phenylalanine; l-proline; l-serine; taurine; l-threonine; l-tryptophan; l-tyrosine; l-valine; calcium chloride; sodium glycerophosphate; magnesium sulfate; potassium chloride; sodium acetate; zinc sulfate; glucose - emulsion for infusion - 0 gram(s) - solutions for parenteral nutrition; combinations

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

biogen nz biopharma ltd - peginterferon beta-1a 94ug;  ; peginterferon beta-1a 63ug - solution for injection - active: peginterferon beta-1a 94ug   excipient: arginine hydrochloride glacial acetic acid polysorbate 20 sodium acetate trihydrate water for injection active: peginterferon beta-1a 63ug excipient: arginine hydrochloride glacial acetic acid polysorbate 20 sodium acetate trihydrate water for injection - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

luminarie group limited - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - active: tranexamic acid 100 mg/ml excipient: water for injection - adults: for the reduction of peri - and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty. paediatrics: for the reduction of peri - and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.

Kanada - englanti - Health Canada

sandoz canada incorporated - tranexamic acid - solution - 100mg - tranexamic acid 100mg - hemostatics

Kanada - englanti - Health Canada

sterimax inc - tranexamic acid - solution - 100mg - tranexamic acid 100mg - hemostatics

Kanada - englanti - Health Canada

methapharm inc - tranexamic acid - solution - 100mg - tranexamic acid 100mg - hemostatics

Kanada - englanti - Health Canada

strides pharma canada inc - tranexamic acid - solution - 100mg - tranexamic acid 100mg - hemostatics

Kanada - englanti - Health Canada

auro pharma inc - tranexamic acid - solution - 100mg - tranexamic acid 100mg - hemostatics